Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection

AIDS. 2008 Mar 30;22(6):685-94. doi: 10.1097/QAD.0b013e3282f4de35.

Abstract

Objectives: Toll-like receptors (TLR) are important in pathogen recognition and may play a role in HIV disease. We evaluated the effect of chronic untreated and treated HIV-1 infection on systemic TLR expression and TLR signalling.

Methods: Two hundred HIV-infected and uninfected women from a Kenya cohort participated in the studies. TLR1 to TLR10 messenger RNA expression was determined by quantitative reverse transcriptase polymerase chain reaction in peripheral blood mononuclear cells (PBMC). TLR ligand responsiveness was determined in or using ex-vivo PBMC by cytokine production in culture supernatants.

Results: Chronic, untreated HIV-1 infection was significantly associated with increased mRNA expression of TLR6, TLR7, and TLR8 and when analysis was limited to those with advanced disease (CD4 cell count < 200 cells/ml) TLR2, TLR3, and TLR4 were additionally elevated. TLR expression correlated with the plasma HIV-RNA load, which was significant for TLR6 and TLR7. In vitro HIV single-stranded RNA alone could enhance TLR mRNA expression. PBMC of HIV-infected subjects also demonstrated profoundly increased proinflammatory responsiveness to TLR ligands, suggesting sensitization of TLR signalling in HIV. Finally, viral suppression by HAART was associated with a normalization of TLR levels.

Conclusion: Together, these data indicate that chronic viraemic HIV-1 is associated with increased TLR expression and responsiveness, which may perpetuate innate immune dysfunction and activation that underlies HIV pathogenesis, and thus reveal potential new targets for therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • Case-Control Studies
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • HIV Infections / metabolism*
  • HIV-1*
  • Humans
  • Kenya
  • Ligands
  • Lymphocyte Activation
  • Lymphocyte Count
  • RNA, Messenger / analysis
  • RNA, Viral / pharmacology
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Toll-Like Receptor 2 / blood
  • Toll-Like Receptor 3 / blood
  • Toll-Like Receptor 4 / blood
  • Toll-Like Receptor 6 / blood
  • Toll-Like Receptor 7 / blood
  • Toll-Like Receptor 8 / blood
  • Toll-Like Receptors / blood*
  • Toll-Like Receptors / metabolism
  • Viral Load
  • Viremia / immunology

Substances

  • Anti-HIV Agents
  • Ligands
  • RNA, Messenger
  • RNA, Viral
  • Toll-Like Receptor 2
  • Toll-Like Receptor 3
  • Toll-Like Receptor 4
  • Toll-Like Receptor 6
  • Toll-Like Receptor 7
  • Toll-Like Receptor 8
  • Toll-Like Receptors